Percutaneous Coronary Intervention in Multivessel Disease and Infarct-Related Cardiogenic Shock: A DanGer Shock Substudy

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • DanGer Shock Investigators - (Author)
  • Department of Internal Medicine and Cardiology (at Dresden Heart Centre)
  • Copenhagen University Hospitals
  • Righospitalet
  • Odense University Hospital
  • Aarhus University Hospital (AUH)
  • University Hospital Duesseldorf
  • Charité – Universitätsmedizin Berlin
  • University Hospital of Würzburg
  • Royal Brompton and Harefield NHS Foundation Trust
  • University of Bonn Medical Center
  • Hannover Medical School (MHH)
  • Hospital of the Brothers of Mercy Trier
  • Jena University Hospital
  • University Hospital Hamburg Eppendorf

Abstract

BACKGROUND: The optimal percutaneous coronary intervention (PCI) strategy in ST-segment elevation myocardial infarction (STEMI)-related cardiogenic shock and multivessel disease remains uncertain.

OBJECTIVES: The aim of this study was to investigate the association between PCI strategy and outcomes in STEMI-related cardiogenic shock and multivessel disease.

METHODS: This exploratory substudy of the DanGer Shock (Danish-German Cardiogenic Shock) multicenter trial included patients with STEMI-related cardiogenic shock and multivessel disease, excluding comatose patients resuscitated from cardiac arrest. Multivessel disease was defined by ≥1 nonculprit angiographic stenosis ≥70%. Patients with an isolated left main culprit were excluded. The planned PCI strategy was registered before randomization. All analyses were performed according to as-treated PCI strategy (immediate multivessel PCI or culprit-only PCI). The primary outcome was all-cause mortality within 180 days; secondary outcomes included renal replacement therapy and acute kidney injury.

RESULTS: Of 355 patients included in the DanGer Shock trial, 221 (72%) had multivessel disease; of these, 118 (53%) were treated with culprit-only PCI and 103 (47%) with immediate multivessel PCI. The median pre-PCI SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) scores were 28 (Q1-Q3: 22-32) and 29 (Q1-Q3: 22-34), respectively. Chronic total occlusion PCI was performed in 6 of 103 patients (6%) treated with immediate multivessel PCI. All-cause mortality was 72 (61%; 95% CI: 52%-70%) in the culprit-only group and 52 (50%; 95% CI: 41%-60%) in the immediate multivessel PCI group (adjusted OR: 0.40; 95% CI: 0.19-0.83) over a median follow-up period of 45 days (Q1-Q3: 2-180 days). Immediate multivessel PCI was not associated with the secondary outcomes. There was no interaction according to randomization allocation and PCI strategy (P = 1.00).

CONCLUSIONS: Immediate multivessel PCI was associated with 60% lower odds of all-cause mortality compared with culprit-only PCI.

Details

Original languageEnglish
Pages (from-to)2226-2237
Number of pages12
JournalJACC. Cardiovascular interventions
Volume18
Issue number18
Publication statusPublished - 22 Sept 2025
Peer-reviewedYes

External IDs

Scopus 105015888801

Keywords

Keywords

  • STEMI, cardiogenic shock, multivessel PCI, multivessel disease